Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 2;16(1):22.
doi: 10.1186/s13293-025-00703-w.

Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring

Affiliations

Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring

Snezana Milosavljevic et al. Biol Sex Differ. .

Abstract

Background: Disruptions in brain development can impact behavioral traits and increase the risk of neurodevelopmental conditions such as autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and bipolar disorder, often in sex-specific ways. Dysregulation of the kynurenine pathway (KP) of tryptophan metabolism has been implicated in cognitive and neurodevelopmental disorders. Increased brain kynurenic acid (KYNA), a neuroactive metabolite implicated in cognition and sleep homeostasis, and variations in the Kmo gene, which encodes kynurenine 3-monooxygenase (KMO), have been identified in these patients. We hypothesize that parental Kmo genetics influence KP biochemistry, sleep behavior and brain energy demands, contributing to impairments in cognition and sleep in offspring through the influence of parental genotype and genetic nurture mechanisms.

Methods: A mouse model of partial Kmo deficiency, Kmo heterozygous (HET-Kmo+/-), was used to examine brain KMO activity, KYNA levels, and sleep behavior in HET-Kmo+/- compared to wild-type control (WT-Control) mice. Brain mitochondrial respiration was assessed, and KP metabolites and corticosterone levels were measured in breast milk. Behavioral assessments were conducted on wild-type offspring from two parental groups: (i) WT-Control from WT-Control parents, (ii) wild-type Kmo (WT-Kmo+/+) from Kmo heterozygous parents (HET-Kmo+/-). All mice were C57Bl/6J background strain. Adult female and male offspring underwent behavioral testing for learning, memory, anxiety-like behavior and sleep-wake patterns.

Results: HET-Kmo+/- mice exhibited reduced brain KMO activity, increased KYNA levels, and disrupted sleep architecture and electroencephalogram (EEG) power spectra. Mitochondrial respiration (Complex I and Complex II activity) and electron transport chain protein levels were impaired in the hippocampus of HET-Kmo+/- females. Breast milk from HET-Kmo+/- mothers increased kynurenine exposure during lactation but corticosterone levels were unchanged. Compared to WT-Control offspring, WT-Kmo+/+ females showed impaired spatial learning, heightened anxiety, reduced sleep and abnormal EEG spectral power. WT-Kmo+/+ males had deficits in reversal learning but no sleep disturbances or anxiety-like behaviors.

Conclusions: These findings suggest that Kmo deficiency impacts KP biochemistry, sleep behavior, and brain mitochondrial function. Even though WT-Kmo+/+ inherit identical genetic material as WT-Control, their development might be shaped by the parent's physiology, behavior, or metabolic state influenced by their Kmo genotype, leading to phenotypic sex-specific differences in offspring.

Keywords: Cognition; Kynurenine pathway; Neurodevelopment; Parental genotype; Sleep.

Plain language summary

Interactions between genetic and environmental factors are carefully regulated during the intricate process of brain development. While genetic information is directly inherited from parents, emerging evidence suggests that parental genetic factors can also shape the environment influencing children’s development in a sex-specific ways. Disruptions in brain development can impact cognitive and behavioral traits and increase the risk of neurodevelopmental conditions such as autism spectrum disorder, attention-deficit/hyperactivity disorder, schizophrenia, and bipolar disorder. This study explored how kynurenine 3-monooxygenase (Kmo) genotype affects female and male mice, focusing on potential sex-specific behavioral changes in offspring born to parents with a genetic disruption in Kmo. We found that female and male mice with partial Kmo deficiency experienced reduced sleep and increased sleep pressure. In female mice, Kmo deficiency impaired mitochondrial energy production in the brain. We also observed alterations in tryptophan metabolism and nutrient composition in the breast milk of Kmo-deficient females. In adult offspring born to Kmo-deficient parents, females exhibited learning difficulties, heightened anxiety-like behaviors, and sleep disturbances. In contrast, male offspring showed mild cognitive impairments but no major sleep issues. These findings highlight that parental Kmo genotype can influence sex differences in cognitive and sleep-related behaviors in offspring. This underscores the importance of considering parental genetic factors when studying neurodevelopmental disorders and associated behavioral outcomes.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: No applicable. Consent for publication: All authors consent to publication of the work. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic diagram of the experimental groups to study the role for parental KMO of the kynurenine pathway in the offspring’s behaviors. A Schematic representation of the kynurenine pathway denoting the pivotal enzyme KMO (in purple color) that is genetically modified in our present mouse model. B Schematic representation of the experimental parental and offspring groups. Wild-type control (WT-Control) breeding pairs and heterozygous Kmo (HET-Kmo+/–) breeding pairs generated wild-type (WT-Control) offspring and wild-type (WT-Kmo+/+) offspring, respectively
Fig. 2
Fig. 2
Decreased KMO activity and increased KYNA in the brain of Kmo heterozygous female and male mice. A Brain KMO activity in HET-Kmo+/– mice is reduced compared to WT-Control mice (Unpaired t test ***P < 0.001, ****P < 0.0001). B Brain KYNA levels in HET-Kmo+/– mice are increased compared to WT-Control mice (Unpaired t test **P < 0.01, ****P < 0.0001). Data are mean ± SEM. N = 5–7 per group
Fig. 3
Fig. 3
HET-Kmo+/– mice have decreased NREM sleep and more wake in comparison to wild-type (WT-Control) mice during the light phase. A Percentage of total time spent in each vigilance state (Unpaired t test **P < 0.01). B Total number of bouts for each vigilance state (Unpaired t test *P < 0.05). C Average bout duration for each vigilance state (Unpaired t test *P < 0.05). D Number of vigilance state transitions (Unpaired t test *P < 0.05). E REM sleep spectral power (Females: Two-way RM ANOVA Genotype x Frequency interaction F(38, 380) = 3.063, ^^^^P < 0.0001; Males: Two-way RM ANOVA Genotype × Frequency interaction F(38, 532) = 3.109, ^^^^P < 0.0001). F NREM sleep spectral power (Females: Two-way RM ANOVA Genotype x Frequency interaction F(38, 380) = 3.799, ^^^^P < 0.0001; Males: Two-way RM ANOVA Genotype × Frequency interaction F(38, 532) = 5.967, ^^^^P < 0.0001). G Relative cage activity (Unpaired t test *P < 0.05). Data are mean ± SEM. N = 6–8 per group
Fig. 4
Fig. 4
HET-Kmo+/– females display substrate-specific changes in hippocampal mitochondrial respiration. A Cortex Complex I-dependent (glutamate/malate) respiration was unchanged between genotypes. B Hippocampus mitochondrial Complex I-dependent State 3 (+ ADP) respiration was significantly decreased in female HET-Kmo+/– versus WT-Control (Welch’s t test *P < 0.05). C Cortex Complex II-dependent (succinate/rotenone) respiration was unchanged between genotypes. D Hippocampus mitochondrial Complex II-dependent respiration was significantly increased in both basal and State 3 respiration in female HET-Kmo+/– versus WT-Control (Welch’s t test *P < 0.05). E Profiling of select mitochondrial oxidative phosphorylation subunits in isolated mitochondria demonstrated a significant upregulation of the ATP5A component of Complex V (CV) in both the cortex and hippocampus of HET-Kmo+/– female mice versus WT-Control. HET-Kmo+/– hippocampal mitochondria also showed a significant decrease in Complex II (CII) SDHB subunit, whereas the CII SDHA subunit increased significantly. F Quantification of mitochondrial proteins measured in cortex (Welch’s t test *P < 0.05). G Quantification of mitochondrial proteins measured in hippocampus (Welch’s t test *P < 0.05, **P < 0.01). Data are mean ± SEM. N = 5 per group for respiratory data, N = 4 per group for immunoblot analysis. Mitochondrial subunit levels were normalized to total protein load as determined by Amido Black staining
Fig. 5
Fig. 5
Breast milk content of kynurenine is elevated in HET-Kmo+/– compared to WT-Control mothers. A Maternal breast milk tryptophan. B Maternal breast milk kynurenine (Unpaired t test ****P < 0.0001). C Maternal breast milk corticosterone. Data are mean ± SEM. N = 7–11 per group
Fig. 6
Fig. 6
Impaired spatial learning in female wild-type (WT-Kmo+/+) offspring from HET-Kmo+/– parents. A Schematic representation of the experimental offspring groups. WT-Control offspring are derived from WT-Control parents. WT-Kmo+/+ offspring are derived from heterozygous Kmo (HET-Kmo+/–) parents. B Distance traveled in the Barnes maze (Female: Two-way RM ANOVA Genotype effect F(1, 36) = 11.08, ^^P < 0.01 with Bonferroni’s post hoc test **P < 0.01). C Errors in the Barnes maze (Female: Two-way RM ANOVA Genotype effect F(1, 36) = 5.311, ^P < 0.05; Male: Two-way RM ANOVA Genotype effect F(1, 40) = 4.391, ^P < 0.05). D Percent of time immobile in the Barnes maze (Female: Two-way RM ANOVA Genotype effect F(1, 24) = 7.1, ^P < 0.05 with Bonferroni’s post hoc test *P < 0.05, **P < 0.01). E Percent of time spent in each search strategy on the Barnes maze (Chi-square distribution test *P < 0.05). F Representative images of video tracking in the Barnes maze across learning trials. Data are mean ± SEM. N = 19–21 per group
Fig. 7
Fig. 7
Impaired reversal learning in male wild-type (WT-Kmo+/+) offspring from HET-Kmo+/– parents. A Distance traveled in the reversal trial of the Barnes maze (Unpaired t-test *P < 0.05). B Errors in the reversal trial of the Barnes maze (Unpaired t-test *P < 0.05). C Percent of time spent in each search strategy in the reversal trial of the Barnes maze. D Representative images of video tracking in the Barnes maze during the reversal trial. Data are mean ± SEM. N = 19–21 per group
Fig. 8
Fig. 8
Increased anxiety-like behavior in female wild-type (WT-Kmo+/+) offspring from HET-Kmo+/– parents. A Distance traveled in the elevated zero maze (Two-way RM ANOVA Genotype effect F(1, 70) = 44.25, ^^^^P < 0.0001 with Fisher’s LSD post hoc test ***P < 0.001, ****P < 0.0001). B Entries to open and closed area in the elevated zero maze (Females: Two-way RM ANOVA Genotype effect F(1, 64) = 14.71, ^^^P < 0.001 with Fisher’s LSD post hoc test *P < 0.05, **P < 0.01). C Number of grooming events in the sucrose splash test (Two-way RM ANOVA Sex effect F(1, 65) = 4.093, ^P < 0.05). D Latency to grooming in the sucrose splash test. Data are mean ± SEM. N = 11–24 per group
Fig. 9
Fig. 9
Female wild-type (WT-Kmo+/+) from HET-Kmo+/– parents have reduced NREM sleep and more wake in comparison to wild-type (WT-Control) mice during the light phase. A Total NREM duration (Females: Two-way RM ANOVA Genotype effect F(1, 10) = 4.776, P = 0.054). B Total wake duration (Females: Two-way RM ANOVA Genotype effect F(1, 10) = 5.584, ^P < 0.05). C NREM sleep spectral power (Females: Two-way RM ANOVA Genotype effect F(1, 10) = 8.711, ^P < 0.05, Genotype × Frequency interaction F(38, 380) = 2.022, ^^^P < 0.001). D REM sleep spectral power (Females: Two-way RM ANOVA Genotype × Frequency interaction F(38, 380) = 1.487, ^P < 0.05). E Relative cage activity (Unpaired t test: *P < 0.05). Data are mean ± SEM. N = 6–10 per group
Fig. 10
Fig. 10
Schematic representation of major findings supporting the conclusion that parental HET-Kmo+/– genotype influences wild-type offspring phenotypes. Disruptions in sleep were observed in female and male HET-Kmo+/– mice, and HET-Kmo+/– female mice had altered hippocampal mitochondria respiration and increased kynurenine levels in breast milk. Even though WT-Kmo+/+ inherit identical genetic material as WT-Control, the present data suggest that behavioral phenotypes of offspring could be shaped by parental physiology, behavior, or metabolic state influenced by their Kmo genotype. Sex-specific differences are noted in offspring. Female WT-Kmo+/+ offspring from HET-Kmo+/– parents exhibit spatial learning impairments, increased anxiety-like behavior, and sleep disturbances. Male WT-Kmo+/+ offspring from HET-Kmo+/– parents display impaired reversal learning, but intact spatial learning, anxiety-like behavior, and sleep patterns

Similar articles

  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • Sexual Harassment and Prevention Training.
    Cedeno R, Bohlen J. Cedeno R, et al. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
  • Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
    Zwi M, Jones H, Thorgaard C, York A, Dennis JA. Zwi M, et al. Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
  • Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM. Johnson WD, et al. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
  • PTS-Related Tetrahydrobiopterin Deficiency (PTPSD).
    Opladen T, Longo N, Blau N. Opladen T, et al. 2025 Jul 10. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2025 Jul 10. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 40638773 Free Books & Documents. Review.

References

    1. Bai D, Yip BHK, Windham GC, Sourander A, Francis R, Yoffe R, et al. Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiat. 2019;76(10):1035. 10.1001/jamapsychiatry.2019.1411. - PMC - PubMed
    1. Brikell I, Kuja-Halkola R, Larsson H. Heritability of attention-deficit hyperactivity disorder in adults. Am J Med Genet B Neuropsychiatr Genet. 2015;168(6):406–13. 10.1002/ajmg.b.32335. - PubMed
    1. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123C(1):48–58. 10.1002/ajmg.c.20013. - PubMed
    1. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait. Arch Gen Psychiatry. 2003;60(12):1187. 10.1001/archpsyc.60.12.1187. - PubMed
    1. Cross-Disorder Group of the Psychiatric Genomics Consortium; Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayés M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisén L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kähler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landén M, Långström N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Mühleisen TW, Muir WJ, Müller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nöthen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM, Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnström K, Reif A, Ribasés M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, Xu W, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zöllner S, Devlin B, Kelsoe JR, Sklar P, Daly MJ, O'Donovan MC, Craddock N, Sullivan PF, Smoller JW, Kendler KS, Wray NR; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:9:984–94. 10.1038/ng.2711. - PMC - PubMed

LinkOut - more resources